Dr. Mohammed Al-Omari

Dr. Mohammed Al-Omari is a Saudi Consultant Pediatric Neurologist and Assistant Professor of Pediatrics at Imam Abdulrahman Bin Faisal University (IAU), Dammam, with his clinical practice based at King Fahad Hospital of the University (King Fahad University Hospital), Al-Khobar. His professional work focuses on pediatric neurology, epilepsy, movement disorders, stroke, neuroimaging, and other neurological disorders affecting children.

Current Positions

Dr. Al-Omari is currently identified as:

• Assistant Professor, Department of Pediatrics, College of Medicine, Imam Abdulrahman Bin Faisal University.
• Pediatric Neurology Consultant, King Fahad University Hospital, Al-Khobar.
• He has also been identified in professional profiles as Chairman of the Department of Pediatrics at Imam Abdulrahman Bin Faisal University.

The Saudi Pediatric Neurology Society lists him as an Assistant Professor in the Pediatric Department at Imam Abdulrahman Bin Faisal University and Pediatric Neurology Consultant at King Fahad University Hospital.

Clinical Expertise

Dr. Al-Omari's documented areas of professional expertise include:

• Pediatric Neurology
• Pediatric epilepsy
• Movement disorders
• Pediatric stroke
• Neuroimaging
• Neurodegenerative diseases
• Clinical neurology
• Neurological disorders in children
• Neurological examination and diagnosis
• Rare pediatric neurological disorders

His work also extends to uncommon and diagnostically challenging pediatric neurological diseases, including autoimmune encephalitis and genetic/structural neurological disorders.

Academic Career

Dr. Al-Omari is an academic faculty member at Imam Abdulrahman Bin Faisal University College of Medicine, where he is involved in pediatric education and clinical academic activities. His ResearchGate profile currently lists 13 publications and 38 citations, with his institutional affiliation verified through Imam Abdulrahman Bin Faisal University.

His involvement in academic medicine combines clinical pediatric neurology with research and education, particularly in neurological conditions that can be difficult to diagnose or manage in children.

Research Contributions

Dr. Al-Omari has contributed to peer-reviewed research in pediatric neurology.

One notable publication is “Anti-NMDA Autoimmune Encephalitis Post-COVID-19 Vaccination in a Pediatric Patient: A Case Report,” published in Neuropediatrics in 2024. The report described a 13-year-old girl who developed anti-NMDA receptor autoimmune encephalitis following COVID-19 vaccination. Dr. Al-Omari was affiliated with both King Fahd Hospital of the University and Imam Abdulrahman Bin Faisal University for this work.

He also contributed to research concerning Moyamoya syndrome in an infant with Aicardi–Goutières and Williams syndromes, published in Neuropediatrics. His affiliation for the work was the Department of Pediatrics at Imam Abdulrahman Bin Faisal University and King Fahd Hospital of the University.

More recently, he was the lead author of a 2025 Frontiers in Pediatrics study titled “Awareness of idiopathic intracranial hypertension in children among pediatricians in Saudi Arabia: a cross-sectional study.” The study investigated pediatricians' knowledge and awareness of idiopathic intracranial hypertension, an important but frequently under-recognized pediatric neurological condition.

Professional Conference Leadership

Dr. Al-Omari has played an important role in the Saudi Pediatric Neurology Society's scientific activities.

He served as Chairman of the 10th Saudi Pediatric Neurology Society Conference, held in Riyadh in November 2025. The conference brought together pediatric neurology specialists from Saudi Arabia and abroad to discuss advances in diagnosis, treatment, research, and clinical practice.

The official SPNS conference program also identifies him as a member of the organizing committee for the 10th conference.

He has additionally served on the Scientific Committee of the Saudi Rare Disease Summit, demonstrating his involvement in education surrounding rare pediatric neurological and genetic disorders.

He has continued to participate as faculty in subsequent SPNS events, including the 11th Saudi Pediatric Neurology Society Conference and Workshops.

Contribution to Rare Disease Awareness

Dr. Al-Omari has been actively involved in Saudi Arabia's pediatric rare-disease community. During the 3rd Saudi Rare Disease Summit in Riyadh in 2025, he spoke publicly about the importance of recognizing rare diseases collectively and improving awareness, collaboration, and care for affected children and families.

His participation in rare-disease scientific committees reflects his broader interest in improving diagnosis and management of complex pediatric neurological conditions.

Advanced Epilepsy Education

Dr. Al-Omari has also participated as an invited faculty member in specialized epilepsy education. He was listed as an invited speaker at the Advanced Epilepsy Management Conference, alongside pediatric neurologists, epileptologists, and clinical neurophysiologists from Saudi Arabia and the region.

Key Achievements

• Pediatric Neurology Consultant at King Fahad University Hospital.
• Assistant Professor of Pediatrics at Imam Abdulrahman Bin Faisal University.
• Identified as Chairman of the Department of Pediatrics at IAU in his academic profile.
• Served as Chairman of the 10th Saudi Pediatric Neurology Society Conference in 2025.
• Member of the Scientific Committee of the Saudi Rare Disease Summit.
• Published research involving pediatric autoimmune encephalitis, including anti-NMDA receptor encephalitis.
• Contributed to research involving Moyamoya syndrome and rare genetic syndromes.
• Lead author of research assessing awareness of pediatric idiopathic intracranial hypertension among Saudi pediatricians.
• Contributed to epilepsy-focused medical education as an invited speaker at an Advanced Epilepsy Management Conference.
• Participated in national and regional pediatric neurology and rare-disease conferences as faculty and committee member.